Aspire Biopharma Holdings Inc [NASDAQ: ASBP] surged by $0.23 during the normal trading session on Monday and reaching a high of $0.875 during the day while it closed the day at $0.59.
Aspire Biopharma Holdings Inc stock has also gained 61.33% of its value over the past 7 days. However, ASBP stock has inclined by 136.95% in the 3 months of the year. Over the past six months meanwhile, it has lost -95.28% and lost -94.64% year-on date.
The market cap for ASBP stock reached $29.22 million, with 49.53 million shares outstanding and 39.39 million shares in the current float. Compared to the average trading volume of 14.79M shares, ASBP reached a trading volume of 465494185 in the most recent trading day, which is why market watchdogs consider the stock to be active.
ASBP stock trade performance evaluation
Aspire Biopharma Holdings Inc [ASBP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 61.33. With this latest performance, ASBP shares gained by 64.80% in over the last four-week period, additionally sinking by -95.28% over the last 6 months – not to mention a drop of -94.87% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ASBP stock in for the last two-week period is set at 70.13, with the RSI for the last a single of trading hit 0.0957, and the three-weeks RSI is set at 0.0759 for Aspire Biopharma Holdings Inc [ASBP]. The present Moving Average for the last 50 days of trading for this stock 0.3592, while it was recorded at 0.4195 for the last single week of trading, and 4.7460 for the last 200 days.
Aspire Biopharma Holdings Inc (ASBP) Capital Structure & Debt Analysis
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
Aspire Biopharma Holdings Inc (ASBP) Efficiency & Liquidity Metrics
Aspire Biopharma Holdings Inc [ASBP]: Institutional Ownership
There are presently around $4.13%, or 6.17%% of ASBP stock, in the hands of institutional investors.
